Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 16Phase NA 12Phase EARLY_PHASE1 4Phase 1/2 3Phase 3 2Phase 2/3 1

Status

Active not recruiting 7Unknown 6Not yet recruiting 5Completed 5Withdrawn 4Terminated 4Recruiting 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 15Neoplasms 11Pancreatic Neoplasms 10Prostatic Neoplasms 7Glioma 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Sarcoma 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Brain Neoplasms 3Pain, Postoperative 2Lymphoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Depression 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2

Interventions

trastuzumab biosimilar HLX02 1pertuzumab 1palbociclib 1olaparib 1niraparib 1eribulin 1entrectinib 1cobimetinib 1atezolizumab 1alovudine 1alectinib 1Vinorelbine 1Vemurafenib 1Trastuzumab 1Taxes 1Specimen Handling 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1Magnetic Resonance Spectroscopy 1Letrozole 1Irinotecan 1Immunoglobulin G 1HhAntag691 1Gemcitabine 1Fulvestrant 1Disulfides 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Sarcoma × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT04877587 2023-02-22

Gemcitabine With Ascorbate Including Adolescents

University of Iowa

Phase EARLY_PHASE1 Withdrawn
Sarcoma

Bone Neoplasms, Sarcoma

NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT03613259 2020-06-09

Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡